서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 81 to 120 of 206

Issue DateTitle / Author(s) / CitationFileAltmetrics
2013-01
KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: A pooled analysis of 2 phase II trials

Kim, Sun Young; Shim, Eun Kyung; Yeo, Hyun Yang; Baek, Ji Yeon; Hong, Yong Sang; Kim, Dae Yong; Kim, Tae Won; Kim, Jee Hyun; Im, Seock-Ah; Jung, Kyung Hae; Chang, Hee Jin

International Journal of Radiation Oncology Biology Physics, Vol.85 No.1, pp.201-207

DOI
2013-05
Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic-polycytidylic acid-induced pneumonia
DOI
2013-06
Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
DOI
2013-07
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
DOI
2013-09
Endoscopic and Histologic Analysis of Gastric Mucosa-Associated Lymphoid Tissue in Children With Helicobacter pylori Infection

Yang, Hye Ran; Choi, Hyoung Soo; Paik, Jin Ho; Lee, Hye Seung

Journal of Pediatric Gastroenterology and Nutrition, Vol.57 No.3, pp.298-304

DOI
2013-09
Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment
DOI
2013-10
The Efficacy of Porous Hydroxyapatite Granule as a Carrier of E.coli-derived Recombinant Human Bone Morphogenetic Protein-2

Lee, Jae Hyup; Baek, Hae-Ri; Lee, Eui-Nam; Lee, Kyung Mee; Lee, Hyun-Kyung

조직공학과 재생의학, Vol.10 No.5, pp.279-285

DOI
2013-10
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth

Kim, Tai Young; Jackson, Sarah; Xiong, Yue; Whitsett, Timothy G.; Lobello, Janine R.; Weiss, Glen J.; Le Tran, Nhan; Bang, Yung-Jue; Der, Channing J.

Proceedings of the National Academy of Sciences of the United States of America, Vol.110 No.42, pp.16868-16873

DOI
2013-12
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
DOI
2013-12
Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines
DOI
2014-05
Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas

Seo, A. N.; Yang, J. M.; Kim, H.; Jheon, S.; Kim, K.; Lee, C. T.; Jin, Y.; Yun, S.; Chung, J-H; Paik, J. H.

British Journal of Cancer, Vol.110 No.11, pp.2688-2699

DOI
2014-06
Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer

Kim, H-P; Han, S-W; Song, S-H; Jeong, E-G; Lee, M-Y; Hwang, D.; Im, S-A; Bang, Y-J; Kim, T-Y

Oncogene, Vol.33 No.25, pp.3334-3341

DOI
2014-07
Lack of transglutaminase 2 diminished T-cell responses in mice
DOI
2014-08
Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer
2014-08
Circulating TNF Receptors Are Significant Prognostic Biomarkers for Idiopathic Membranous Nephropathy
DOI
2014-11
An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
DOI
2014-11
CXCR4 antagonist inhibits perineural invasion of adenoid cystic carcinoma

Jeong, Woo-Jin; Choi, Ik Joon; Park, Min-Woo; An, Soo-Youn; Jeon, Eun-Hui; Paik, Jin Ho; Sung, Myung-Whun; Ahn, Soon-Hyun

Journal of Clinical Pathology - Clinical Molecular Pathology, Vol.67 No.11, pp.992-998

DOI
2014-12
Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas
DOI
2015-01
An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients
DOI
2015-03
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
view fileDOI
2015-04
Thalidomide inhibits alternative activation of macrophages in vivo and in vitro: A potential mechanism of anti-asthmatic effect of thalidomide
DOI
2015-06
Thymic low affinity/avidity interaction selects natural Th1 cells
DOI
2015-06
MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma
DOI
2015-07
Circulating tumor necrosis factor a receptors predict the outcomes of human IgA nephropathy: A prospective cohort study
DOI
2015-08
Metabolic characteristics of advanced biliary tract cancer using F-18-fluorodeoxyglucose positron emission tomography and their clinical implications
DOI
2015-10
High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy
DOI
2015-10
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations
view fileDOI
2015-11
Randomized, double-blind phase II trial with prospective classification by ATM protein level to evaluate the efficacy and tolerability of olaparib plus paclitaxel in patients with recurrent or metastatic gastric cancer
DOI
2015-11
Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells
view fileDOI
2015-11
Effect of lapatinib on oral digoxin absorption in patients
DOI
2016-01
Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer

Kim, Ji-Won; Kim, Debora K.; Min, Ahrum; Lee, Kyung-Hun; Nam, Hyun-Jin; Kim, Jee Hyun; Kim, Jin-Soo; Kim, Tae-Yong; Im, Seock-Ah; Park, In Ae

Journal of Cancer Research and Clinical Oncology, Vol.142 No.1, pp.157-165

DOI
2016-02
Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer
DOI
2016-02
Lapatinib in combination with capecitabine plus oxaliplatin in human epidermal growth factor receptor 2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma: TRIO-013/LOGiC-A randomized phase III trial
DOI
2016-02
MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma
DOI
2016-03
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
DOI
2016-04
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
DOI
2016-04
SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer
DOI
2016-04
VEGF and Ki-67 overexpression in predicting poor overall survival in adenoid cystic carcinoma
view fileDOI
2016-05
Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-cell infiltration
DOI
2016-08
Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer
DOI
1 2 3 4 5 66